CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
CD22 靶向 CAR-T 细胞可诱导初治或对 CD19 靶向 CAR 免疫疗法有抗性的 B-ALL 患者缓解
期刊:Nature Medicine
影响因子:58.7
doi:10.1038/nm.4441
Terry J Fry, Nirali N Shah, Rimas J Orentas, Maryalice Stetler-Stevenson, Constance M Yuan, Sneha Ramakrishna, Pamela Wolters, Staci Martin, Cindy Delbrook, Bonnie Yates, Haneen Shalabi, Thomas J Fountaine, Jack F Shern, Robbie G Majzner, David F Stroncek, Marianna Sabatino, Yang Feng, Dimiter S Dim
